Design of novel human microbiome-derived peptides for inhibition of OXA-48 Carbapenemase: An in-silico and in-vitro approach
Microbial Pathogenesis · 2025
DOI: 10.1016/j.micpath.2025.107779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von Solmaz Sadeghi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran; Department of …. Hauptthemen laut MEDLINE: beta-Lactamases, Bacterial Proteins, Antimicrobial Peptides, beta-Lactamase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Tehran University of Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran; Department of Microbiology, School of Medicine, Tehran University of Medical Science…
- Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: siroosim@sina.tums.ac.ir.
Förderung
- Tehran University of Medical Sciences
Zitieren
APA
Sadeghi, S., Faramarzi, M. A., & Siroosi, M. (2025). Design of novel human microbiome-derived peptides for inhibition of OXA-48 Carbapenemase: An in-silico and in-vitro approach. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.107779
Vancouver
Sadeghi S, Faramarzi MA, Siroosi M. Design of novel human microbiome-derived peptides for inhibition of OXA-48 Carbapenemase: An in-silico and in-vitro approach. Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.107779
BibTeX
@article{Sadeghi2025,
author = {Sadeghi, Solmaz and Faramarzi, Mohammad Ali and Siroosi, Maryam},
title = {Design of novel human microbiome-derived peptides for inhibition of OXA-48 Carbapenemase: An in-silico and in-vitro approach},
journal = {Microbial Pathogenesis},
year = {2025},
doi = {10.1016/j.micpath.2025.107779}
}
EUVIMED